immunotherapy

ASCO20 Virtual Scientific Program; Research Round Up Podcast Series
June 23, 2020 · Claire Smith, ASCO staff
In this podcast, Cancer.Net Associate Editors share exciting research from the ASCO20 Virtual Scientific Program. Read More >>
ASCO20 Virtual Scientific Program: #ASCO20
May 28, 2020 · Brielle Gregory, ASCO staff
Read research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on immunotherapy for metastatic colorectal cancer and gestational trophoblastic disease, maintenance therapy for advanced bladder cancer, the potential of precision medicine for childhood cancers, and targeted therapy after surgery for EGFR-positive non-small cell lung cancer. Read More >>
ASCO20 Virtual Scientific Program: #ASCO20
May 28, 2020 · Brielle Gregory, ASCO staff
Lea los puntos destacados de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Incluyen estudios sobre inmunoterapia para el cáncer colorrectal metastásico y la enfermedad trofoblástica gestacional, terapia de mantenimiento para el cáncer de vejiga avanzado, el potencial de la medicina de precisión para el cáncer infantil y la terapia dirigida después de la cirugía por EGFR (receptor del factor de crecimiento epidérmico), positivo de cáncer de pulmón de células no pequeñas. Read More >>
February 13, 2020 · Brielle Gregory, ASCO staff
In the first podcast of the Clinical Trials in Genitourinary Cancers series, experts discuss 3 clinical trials that are currently exploring new ways of treating kidney, bladder, and prostate cancers. Read More >>
Ricardo Cubedo, MD
November 14, 2019 · Greg Guthrie, ASCO staff
Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment. Read More >>

Pages